Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (se deschide o fereastră nouă)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Sursă‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Index‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (se deschide o fereastră nouă)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (se deschide o fereastră nouă)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Sursă‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Index‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (se deschide o fereastră nouă)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (se deschide o fereastră nouă)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Sursă‎: Ann Surg 2019;269(5):794-804.

Index‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (se deschide o fereastră nouă)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (se deschide o fereastră nouă)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Sursă‎: Spine 2009;34(19):2096-103.

Index‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (se deschide o fereastră nouă)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (se deschide o fereastră nouă)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Sursă‎: J Orthop Surg 2017;25(1):2309499016684725.

Index‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (se deschide o fereastră nouă)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (se deschide o fereastră nouă)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Sursă‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Index‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (se deschide o fereastră nouă)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (se deschide o fereastră nouă)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Sursă‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Index‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (se deschide o fereastră nouă)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (se deschide o fereastră nouă)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Sursă‎: J Knee Surg 2017;30(5):460-6.

Index‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (se deschide o fereastră nouă)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (se deschide o fereastră nouă)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Sursă‎: J Arthroplasty 2017;32(8):2375-80.

Index‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (se deschide o fereastră nouă)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (se deschide o fereastră nouă)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Sursă‎: Am J Orthop 2016;45(7):E439-43.

Index‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (se deschide o fereastră nouă)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (se deschide o fereastră nouă)

Dobosz B, Dutka J, Dutka L, Maleta P.

Sursă‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

Index‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (se deschide o fereastră nouă)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (se deschide o fereastră nouă)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Sursă‎: Spine J 2017;17(7):977-82.

Index‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (se deschide o fereastră nouă)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (se deschide o fereastră nouă)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Sursă‎: Orthop Clin North Am 2017;48(2):109-15.

Index‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (se deschide o fereastră nouă)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (se deschide o fereastră nouă)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Sursă‎: Ir Med J 2018;111(4):730.

Index‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (se deschide o fereastră nouă)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (se deschide o fereastră nouă)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Sursă‎: Anesth Analg 2022;135(3):576-85.

Index‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (se deschide o fereastră nouă)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (se deschide o fereastră nouă)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Sursă‎: J Orthop Surg Res 2014;9:50.

Index‎: PubMed 24997589

DOI‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (se deschide o fereastră nouă)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (se deschide o fereastră nouă)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Sursă‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Index‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (se deschide o fereastră nouă)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (se deschide o fereastră nouă)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Sursă‎: Transfusion 2017;57(2):357-66.

Index‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (se deschide o fereastră nouă)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (se deschide o fereastră nouă)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Sursă‎: J Arthroplasty 2013;28(8 Suppl):137-9.

Index‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (se deschide o fereastră nouă)

Cell saver for adult spinal deformity surgery reduces cost. (se deschide o fereastră nouă)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Sursă‎: Spine Deform 2017;5(4):272-6.

Index‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (se deschide o fereastră nouă)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (se deschide o fereastră nouă)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Sursă‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Index‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (se deschide o fereastră nouă)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (se deschide o fereastră nouă)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Sursă‎: Orthopedics 2017;40(6):e1044-9.

Index‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (se deschide o fereastră nouă)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (se deschide o fereastră nouă)

Harris RN, Moskal JT, Capps SG.

Sursă‎: J Arthroplasty 2015;30(2):192-5.

Index‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (se deschide o fereastră nouă)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (se deschide o fereastră nouă)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Sursă‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Index‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (se deschide o fereastră nouă)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (se deschide o fereastră nouă)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Sursă‎: Bone Jt Open 2022;3(7):536-42.

Index‎: PubMed 35816170

DOI‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (se deschide o fereastră nouă)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (se deschide o fereastră nouă)

Kotzé A, Carter LA, Scally AJ.

Sursă‎: Br J Anaesth 2012;108(6):943-52.

Index‎: PubMed 22593128

DOI‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (se deschide o fereastră nouă)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (se deschide o fereastră nouă)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Sursă‎: Transfusion 2017;57(6):1347-58.

Index‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (se deschide o fereastră nouă)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (se deschide o fereastră nouă)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Sursă‎: Br J Anaesth 2007;99(6):794-800.

Index‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (se deschide o fereastră nouă)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (se deschide o fereastră nouă)

Mehra A, Murray J, DeAlwis C.

Sursă‎: Ann R Coll Surg Engl 2004;86(4):260-2.

Index‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (se deschide o fereastră nouă)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (se deschide o fereastră nouă)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Sursă‎: J Arthroplasty 2018;33(6):1705-12.

Index‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (se deschide o fereastră nouă)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (se deschide o fereastră nouă)

Moskal JT, Harris RN, Capps SG.

Sursă‎: J Arthroplasty 2015;30(3):365-8.

Index‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (se deschide o fereastră nouă)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (se deschide o fereastră nouă)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Sursă‎: Blood Transfus 2013;11(2):260-71.

Index‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (se deschide o fereastră nouă)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (se deschide o fereastră nouă)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Sursă‎: Blood Transfus 2014;12(1):40-9.

Index‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (se deschide o fereastră nouă)

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (se deschide o fereastră nouă)

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Sursă‎: Transfusion 2011;51(1):118-24.

Index‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 (se deschide o fereastră nouă)

Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (se deschide o fereastră nouă)

Nichols CI, Vose JG.

Sursă‎: J Arthroplasty 2016;31(3):583-589.e1.

Index‎: PubMed 26699673

DOI‎: 10.1016/j.arth.2015.10.013

https://www.ncbi.nlm.nih.gov/pubmed/26699673 (se deschide o fereastră nouă)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (se deschide o fereastră nouă)

Örs Ç, Çaylak R.

Sursă‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Index‎: PubMed 34730529

DOI‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (se deschide o fereastră nouă)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (se deschide o fereastră nouă)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Sursă‎: Open Orthop J 2011;5:44-8.

Index‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (se deschide o fereastră nouă)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (se deschide o fereastră nouă)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

Sursă‎: Anesth Analg 2022;135(3):448-58.

Index‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (se deschide o fereastră nouă)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (se deschide o fereastră nouă)

Phan DL, Ani F, Schwarzkopf R.

Sursă‎: J Arthroplasty 2016;31(3):579-82.

Index‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (se deschide o fereastră nouă)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (se deschide o fereastră nouă)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Sursă‎: Transfusion 2016;56(2):466-71.

Index‎: PubMed 26509250

DOI‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (se deschide o fereastră nouă)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (se deschide o fereastră nouă)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Sursă‎: BMJ 2014;349:g4829.

Index‎: PubMed 25116268

DOI‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (se deschide o fereastră nouă)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (se deschide o fereastră nouă)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Sursă‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Index‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (se deschide o fereastră nouă)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (se deschide o fereastră nouă)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Sursă‎: J Arthroplasty 2018;33(7):2092-9.e9.

Index‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (se deschide o fereastră nouă)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (se deschide o fereastră nouă)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Sursă‎: Transfus Med 2009;19(4):202-6.

Index‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (se deschide o fereastră nouă)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (se deschide o fereastră nouă)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Sursă‎: Int Orthop 2019;43(1):39-46.

Index‎: PubMed 30232527

DOI‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (se deschide o fereastră nouă)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (se deschide o fereastră nouă)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Sursă‎: Int Orthop 2019;43(12):2707-14.

Index‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (se deschide o fereastră nouă)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (se deschide o fereastră nouă)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Sursă‎: J Orthop Surg Res 2011;6:22.

Index‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (se deschide o fereastră nouă)

Increased hospital costs associated with red blood cell transfusion. (se deschide o fereastră nouă)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Sursă‎: Transfusion 2015;55(5):1082-9.

Index‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (se deschide o fereastră nouă)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (se deschide o fereastră nouă)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Sursă‎: J Arthroplasty 2014;29(8):1512-5.

Index‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (se deschide o fereastră nouă)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (se deschide o fereastră nouă)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Sursă‎: J Arthroplasty 2020;35(11):3084-8.

Index‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (se deschide o fereastră nouă)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (se deschide o fereastră nouă)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Sursă‎: Thromb Res 2018;171:143-8.

Index‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (se deschide o fereastră nouă)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (se deschide o fereastră nouă)

Ye X, Lafuma A, Torreton E, Arnaud A.

Sursă‎: BMC Health Serv Res 2013;13:186.

Index‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (se deschide o fereastră nouă)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (se deschide o fereastră nouă)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Sursă‎: Int Orthop 2007;31(3):303-8.

Index‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (se deschide o fereastră nouă)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (se deschide o fereastră nouă)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Sursă‎: Medicine 2017;96(52):e9552.

Index‎: PubMed 29384974

DOI‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (se deschide o fereastră nouă)